Eclipse XL1’s Path to the First-in-Human Study; Andre Bessette, Chief Executive Officer at Eclipse Regenesis Inc. and James Dunn, MD, PhD, Professor of Surgery and Bioengineering, Stanford School of Medicine
Back to All Events
Earlier Event: September 1
Innovators Forum: Low-Cost Non-Invasive Ventilators for COVID-19
Later Event: September 22
Innovators Forum: Nano Force Sensors Technology and use in Surgical Robotics